Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantationKenneth Micklethwaite, Anna Hansen, Aaron Foster, et al.
Bone Research|June 29, 2023
A novel multifunctional radioprotective strategy using P7C3 as a countermeasure against ionizing radiation-induced bone lossFei Wei, Zewen Kelvin Tuong, Mahmoud Omer, et al.
Advanced Healthcare Materials|January 10, 2026
A Novel Bone Shield to Improve Skeletal Health during Space Exploration and for Disuse Conditions on EarthFei Wei, Christopher Ngo, Craig J Neal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemiaEttore Biagi, Raphael Rousseau, Eric Yvon, et al.
Nutrients|August 12, 2022
Omega-9 Modifies Viscoelasticity and Augments Bone Strength and Architecture in a High-Fat Diet-Fed Murine ModelMahmoud Omer, Hessein Ali, Nina Orlovskaya, et al.
Bioactive Materials|October 3, 2022
A novel approach for the prevention of ionizing radiation-induced bone loss using a designer multifunctional cerium oxide nanozymeFei Wei, Craig J Neal, Tamil Selvan Sakthivel, et al.
Nutrients|March 11, 2023
The Effect of Omega-9 on Bone Viscoelasticity and Strength in an Ovariectomized Diet-Fed Murine ModelMahmoud Omer, Christopher Ngo, Hessein Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activityAlana A Kennedy-Nasser, Stephanie Ku, Paul Castillo-Caro, et al.
Plos One|February 23, 2024
Halofuginone for non-hospitalized adult patients with COVID-19 a multicenter, randomized placebo-controlled phase 2 trial. The HALOS trialBruno Martins Tomazini, Lucas Tramujas, Fernando Azevedo Medrado, et al.
Pageof 2